The Trump administration's "short pause" on communications, expected to end on Feb. 1, has affected FDA updates on food contamination investigations.

Overseas, health authorities have been closely watching several emerging disease threats, including the possibility of a Marburg virus ... reaction to a multiple sclerosis medication.

A number of other health agencies are also operating without acting heads, including the FDA and the National Institutes of Health.

Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...

Mothers with multiple sclerosis had an elevated incidence and prevalence of peripartum mental illness vs. mothers without MS ...

The onset of multiple sclerosis (MS) in older individuals correlates with a higher risk of developing primary progressive MS, faster progression to secondary progressive MS, and increased disability ...

Multiple sclerosis (MS) is one of the most widespread disabling neurological conditions of young adults around the world. It affects almost 1 million people in the United States, and about 2.9 ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...